Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group
18 Years
46 Years
Female
Polycystic Ovary Syndrome
Trial Information
Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group
Polycystic ovarian syndrome (PCOS) is the most frequent endocrine disorder of reproductive
age women, affecting an estimated 9-18% of all women in this age group. To diagnose of PCOS
in early life is especially important because it is now thought to increase metabolic and
cardiovascular risks. Investigating PCOS is crucial as it is now considered to increase
metabolic and cardiovascular risk, thereby impacting the health of women to a much greater
extent than previously thought. We are plan using retrospective analysis to evaluate the
clinical and biochemical presentation of PCOS in different aged groups.
Inclusion Criteria:
- Reproductive age women with sufficient data
Exclusion Criteria:
- Disorders of uterus (e.g. Asherman's Syndrome, Mullerian agenesis) and chromosomal
anomalies (e.g. Turner syndrome)
- women who had had menarche at less than 3 years of age, Day 3 FSH > 15, or who were
older than 46
- women with inadequate clinical/biochemical records
- and women who had had ovarian cysts or ovarian tumors in ultrasonography examination
- pregnancy women
Type of Study:
Observational
Study Design:
Time Perspective: Retrospective
Principal Investigator
Ming-I Hsu
Investigator Role:
Principal Investigator
Investigator Affiliation:
Taipei Medical University WanFang Hospital
Authority:
Taiwan: Department of Health
Study ID:
WFH-PCOS-100002
NCT ID:
NCT01350895
Start Date:
February 2011
Completion Date:
April 2012
Related Keywords:
- Polycystic Ovary Syndrome
- Polycystic ovarian syndrome (PCOS)
- Polycystic Ovary Syndrome
Name | Location |
|---|
